Cited by 1,020Schizophrenia research and treatmentNeuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.

NMDA receptor hypofunction model of schizophrenia

Olney, John W, Newcomer, John W, Farber, Nuri B·1999·Journal of Psychiatric Research

DOI 10.1016/s0022-3956(99)00029-1

Open this paper in CoChat — free account

Abstract

Several decades of research attempting to explain schizophrenia in terms of the dopamine hyperactivity hypothesis have produced disappointing results. A new hypothesis focusing on hypofunction of the NMDA glutamate transmitter system is emerging as a potentially more promising concept. In this article, we present a version of the NMDA receptor hypofunction hypothesis that has evolved from our recent studies pertaining to the neurotoxic and psychotomimetic effects of PCP and related NMDA antagonist drugs. In this article, we examine this hypothesis in terms of its strengths and weaknesses, its therapeutic implications and ways in which it can be further tested.

Integrity signals

Registry

Crossref · 10.1016/s0022-3956(99)00029-1

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Excitatory Amino Acid Transmitters
Watkins, J. C., & Evans, R. H. (1981) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.001121 · Cited by 2,497
Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain
Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055
Self-citation
Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Self-citation
Ketamine—its pharmacology and therapeutic uses
white, P. F., Way, W. L., & Trevor, A. J. (1982) · Anesthesiology · doi:10.1097/00000542-198202000-00007 · Cited by 1,474
Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related Drugs
Olney, J. W., Labruyere, J., & Price, M. T. (1989) · Science · doi:10.1126/science.2660263 · Cited by 1,230
Self-citation
Study of a New Schizophrenomimetic Drug—Sernyl
LUBY, E. D. (1959) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1959.02340150095011 · Cited by 921

Show all 63 references

Research works printed but not linked: 7

Anand, 1997, Reduction in ketamine effects in humans by lamotrigine, Society for Neuroscience Abstracts, 23, 1755
Farber, 1997, Costimulation of muscarinic and nonNMDA glutamate receptors reproduces NMDA antagonist neurotoxicity, Society for Neuroscience Abstracts, 23, 2308
Newcomer, 1998, Guanabenz effects on NMDA antagonist-induced mental symptoms in humans, Society for Neuroscience Abstracts, 24, 525
Newcomer JW, Selke G, Melson A, White DA, Roediger HL, Farber NB, Wozniak DF, Jevtovic-Todorovic V, Olney JW. NMDA antagonist-induced decreases in working and explicit memory in humans. Society for Neuroscience Abstracts 1999b;25 (in press).
Olney, 1998, Alcohol induces massive apoptotic neurodegeneration in the developing rat CNS, Society for Neuroscience Abstracts, 24, 1983
Olney JW, Wozniak DF, Price MT, Tenkova TI, Dikranian K, Ikonomidou C. Ethanol induces widespread apoptotic neurodegeneration in the infant mouse brain. Society for Neuroscience Abstracts 1999;25 (in press).
Price MT, Wozniak DF, Tenkova TI, Dikranian K, Ikonomidou C, Olney JW. Ethanol induces widespread apoptotic neurodegeneration in the fetal guinea pig brain. Society for Neuroscience Abstracts 1999;25 (in press).

Sorted by citations

Items 201–300 of 999

The darker side of Ca signaling by neuronal Ca-sensor proteins: from Alzheimer's disease to cancer
Braunewell, K. H. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.04.008 · Cited by 88
Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia
Gaisler-Salomon, I., Miller, G. M., Chuhma, N., Lee, S., Zhang, H., Ghoddoussi, F., Lewandowski, N., Fairhurst, S., Wang, Y., Conjard-Duplany, A., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.58 · Cited by 86
Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms
McGregor, C., Riordan, A. J., & Thornton, J. E. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.06.003 · Cited by 90
Mouse fMRI under ketamine and xylazine anesthesia: Robust contralateral somatosensory cortex activation in response to forepaw stimulation
Shim, H., Jung, W. B., Schlegel, F., Lee, J., Kim, S., Lee, J., & Kim, S. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.04.062 · Cited by 86
Different oxysterols have opposing actions at N-methyl-d-aspartate receptors
Linsenbardt, A. J., Taylor, A., Emnett, C. M., Doherty, J., Krishnan, K., Covey, D. F., Paul, S. M., Zorumski, C. F., & Mennerick, S. J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.027 · Cited by 85
Reduced serial dependence suggests deficits in synaptic potentiation in anti-NMDAR encephalitis and schizophrenia
Stein, H., Barbosa, J., Rosa-Justícia, M., Prades, L., Morató, A., Galan-Gadea, A., Ariño, H., Martínez‐Hernández, E., Castro‐Fornieles, J., Dalmau, J. O., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18033-3 · Cited by 80
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis
Egerton, A., Stone, J., Chaddock, C. A., Barker, G., Bonoldi, I., Howard, R. M., Merritt, K., Allen, P., Howes, O., Murray, R., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.143 · Cited by 94
Electroencephalographic Spectral and Coherence Analysis of Ketamine in Rats: Correlation with Behavioral Effects and Pharmacokinetics
Páleníček, T., Fujáková, M., Brunovský, M., Balı́ková, M., Horáček, J., Gorman, I., Tylš, F., Tislerova, B., Šóš, P., Bubeníková‐Valešová, V., et al. (2011) · Neuropsychobiology · doi:10.1159/000321803 · Cited by 91
The discovery of susceptibility genes for mental disorders
Cloninger, C. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222532599 · Cited by 85
The Neurotoxicity of Nitrous Oxide: The Facts and “Putative” Mechanisms
Savage, S., & Ma, D. (2014) · Brain Sciences · doi:10.3390/brainsci4010073 · Cited by 89
Dysregulation of thalamic sensory ‘transmission’ in schizophrenia: neurochemical vulnerability to hallucinations
Behrendt, R. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881105057696 · Cited by 83
Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized 1H MRS study
Iltis, I., Koski, D. M., Eberly, L. E., Nelson, C. D., Deelchand, D. K., Valette, J., Uǧurbil, K., Lim, K. O., & Henry, P. (2009) · NMR in Biomedicine · doi:10.1002/nbm.1385 · Cited by 83
Dizocilpine (MK-801) induces distinct changes of N-methyl-d-aspartic acid receptor subunits in parvalbumin-containing interneurons in young adult rat prefrontal cortex
Dong, X., Zhang, W., Wang, H.-X., Stradtman, G. G., & Gao, W. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570900042x · Cited by 84
Transitory glutathione deficit during brain development induces cognitive impairment in juvenile and adult rats: Relevance to schizophrenia
Cabungcal, J.-H., Preissmann, D., Delseth, C., Cuénod, M., Kim, Q., & Schenk, F. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.03.001 · Cited by 83
S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: Clinical implications for the role of S100B in excitotoxic brain injury
Kögel, D., Peters, M., König, H.-G., Hashemi, S. M. A., Bui, N. T., Arolt, V., Rothermundt, M., & Prehn, J. H. M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.013 · Cited by 82
Dissecting the Contribution of Individual Receptor Subunits to the Enhancement of N-methyl-d-Aspartate Currents by Dopamine D1 Receptor Activation in Striatum
Jocoy, E. L., André, V. M., Cummings, D. M., Rao, S. P., Wu, N., Ramsey, A. J., Caron, M. G., Cepeda, C., & Levine, M. S. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00004 · Cited by 80
d-Serine and a glycine transporter-1 inhibitor enhance social memory in rats
Shimazaki, T., Kaku, A., & Chaki, S. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1794-y · Cited by 81
Ketamine effects on brain function — Simultaneous fMRI/EEG during a visual oddball task
Musso, F., Brinkmeyer, J., Ecker, D., London, M. K., Thieme, G., Warbrick, T., Wittsack, H., Saleh, A., Greb, W., de Boer, P., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.06.045 · Cited by 80
Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disorders
Abbas, A. I., & Roth, B. L. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802532707 · Cited by 81
Structural Determinants and Mechanism of Action of a GluN2C-selective NMDA Receptor Positive Allosteric Modulator
Khatri, A., Burger, P. B., Swanger, S. A., Hansen, K. B., Zimmerman, S. S., Karakaş, E., Liotta, D. C., Furukawa, H., Snyder, J. P., & Traynelis, S. F. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094516 · Cited by 82
NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI
Northoff, G., Richter, A., Bermpohl, F., Grimm, S., Martin, E., Marcar, V. L., Wahl, C., Hell, D., & Boeker, H. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.04.009 · Cited by 82
Comprehensive review: Computational modelling of schizophrenia
Valton, V., Romaniuk, L., Steele, J. D., Lawrie, S. M., & Seriès, P. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.022 · Cited by 82
Impaired prefrontal synaptic gain in people with psychosis and their relatives during the mismatch negativity
Ranlund, S., Adams, R. A., Díez, Á., Constante, M., Dutt, A., Hall, M., Maestro Carbayo, A., McDonald, C., Petrella, S., Schulze, K., et al. (2016) · Human Brain Mapping · doi:10.1002/hbm.23035 · Cited by 77
Ion channels in EEG: isolating channel dysfunction in NMDA receptor antibody encephalitis
Symmonds, M., Moran, C., Leite, M. I., Buckley, C. J., Irani, S. R., Stephan, K. E., Friston, K. J., & Moran, R. (2018) · Brain · doi:10.1093/brain/awy107 · Cited by 74
Clozapine Prevents a Decrease in Neurogenesis in Mice Repeatedly Treated With Phencyclidine
Maeda, K., Sugino, H., Hirose, T., Kitagawa, H., Nagai, T., Mizoguchi, H., Takuma, K., & Yamada, K. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0061424 · Cited by 76
Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia
Begni, S., Moraschi, S., Bignotti, S., Fumagalli, F., Rillosi, L., Pérez, J., & Gennarelli, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01783-3 · Cited by 77
New drug developments in psychosis: Challenges, opportunities and strategies
Keshavan, M. S., Lawler, A. N., Nasrallah, H. A., & Tandon, R. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.07.004 · Cited by 79
L-Theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients With Schizophrenia and Schizoaffective Disorder: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, 2-Center Study
Ritsner, M. S., Miodownik, C., Ratner, Y., Shleifer, T., Mar, M., Pintov, L., & Lerner, V. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05324gre · Cited by 74
Prefrontal Cortical Gamma-Aminobutyric Acid Transmission and Cognitive Function: Drawing Links to Schizophrenia from Preclinical Research
Tse, M., Piantadosi, P. T., & Floresco, S. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.09.007 · Cited by 77
Selective phosphodiesterase inhibitors improve performance on the ED/ID cognitive task in rats
Rodefer, J. S., Saland, S. K., & Eckrich, S. J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.008 · Cited by 74
Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice
Featherstone, R. E., Liang, Y., Saunders, J. A., Tatard-Leitman, V. M., Ehrlichman, R. S., & Siegel, S. J. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.003 · Cited by 75
Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia
Levkovitz, Y., Levi, U., Braw, Y., & Cohen, H. (2007) · Brain Research · doi:10.1016/j.brainres.2007.03.080 · Cited by 74
DTI and Myelin Plasticity in Bipolar Disorder: Integrating Neuroimaging and Neuropathological Findings
Bellani, M., Boschello, F., Delvecchio, G., Dusi, N., Altamura, C. A., Ruggeri, M., & Brambilla, P. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00021 · Cited by 75
Classics in Chemical Neuroscience: Haloperidol
Tyler, M. W., Zaldívar-Díez, J., & Haggarty, S. J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00018 · Cited by 77
Preliminary evidence for a link between schizophrenia and NMDA–glycine site receptor ligand metabolic enzymes, d -amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1)
Kapoor, R., Lim, K. S., Cheng, A., Garrick, T. M., & Kapoor, V. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.082 · Cited by 73
The cerebellum and neuropsychiatric disorders
Villanueva, R. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.02.023 · Cited by 77
Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: Implications for abnormalities of glutamate release and NMDA–CaMKII signaling
Murai, R., Noda, Y., Matsui, K., Kamei, H., Mouri, A., Matsuba, K., Nitta, A., Furukawa, H., & Nabeshima, T. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.03.003 · Cited by 73
The difference in Mismatch negativity between the acute and post-acute phase of schizophrenia
Shinozaki, N., Yabe, H., Sato, Y., Hiruma, T., Sutoh, T., Nashida, T., Matsuoka, T., & Kaneko, S. (2002) · Biological Psychology · doi:10.1016/s0301-0511(01)00129-6 · Cited by 73
Characteristics of fMRI responses to visual stimulation in anesthetized vs. awake mice
Dinh, T. N. A., Jung, W. B., Shim, H., & Kim, S. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117542 · Cited by 70
Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain
Ceresoli‐Borroni, G., Rassoulpour, A., Wu, H., Guidetti, P., & Schwarcz, R. M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0432-z · Cited by 72
Ketamine-enhanced immobility in forced swim test: A possible animal model for the negative symptoms of schizophrenia
Chindo, B. A., Adzu, B., Yahaya, T. A., & Gamaniel, K. S. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.04.018 · Cited by 71
Novel NMDA receptor modulators: an update
Santangelo, R., Acker, T. M., Zimmerman, S. S., Katzman, B. M., Strong, K. L., Traynelis, S. F., & Liotta, D. C. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.728587 · Cited by 72
Withdrawal from Chronic Phencyclidine Treatment Induces Long-Lasting Depression in Brain Reward Function
Spielewoy, C., & Markou, A. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300124 · Cited by 73
NMDA 2A receptors in parvalbumin cells mediate sex-specific rapid ketamine response on cortical activity
Picard, N., Takesian, A. E., Fagiolini, M., & Hensch, T. K. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0341-9 · Cited by 71
Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?
Li, M.-L., Hu, X., Li, F., & Gao, W. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.02.012 · Cited by 71
Nobiletin, a Citrus Flavonoid, Reverses Learning Impairment Associated with N-Methyl-D-aspartate Receptor Antagonism by Activation of Extracellular Signal-Regulated Kinase Signaling
Nakajima, A., Yamakuni, T., Matsuzaki, K., Nakata, N., Onozuka, H., Yokosuka, A., Sashida, Y., Mimaki, Y., & Ohizumi, Y. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.117010 · Cited by 71
Ketamine-Induced Oscillations in the Motor Circuit of the Rat Basal Ganglia
Nicolás, M. J., López‐Azcárate, J., Valencia, M., Alegre, M., Pérez-Alcázar, M., Iriarte, J., & Artieda, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021814 · Cited by 71
Altered intrinsic and extrinsic connectivity in schizophrenia
Zhou, Y., Zeidman, P., Wu, S., Razi, A., Cheng Ann, C. H. E. N., Yang, L., Zou, J., Wang, G., Wang, H., & Friston, K. J. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.12.006 · Cited by 68
The potential role of lamotrigine in schizophrenia
Large, C. H., Webster, E. L., & Goff, D. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0020-9 · Cited by 69
Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness
Breese, G. R., Knapp, D. J., & Moy, S. S. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(02)00011-8 · Cited by 69
Neurobiology of early psychosis
Keshavan, M. S., Berger, G. E., Zipursky, R. B., Pantelis, C., Wood, S. J., & Pantelis, C. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.187.48.s8 · Cited by 69
Animal Models of Psychosis: Current State and Future Directions
Forrest, A. D., Coto, C. A., & Siegel, S. J. (2014) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-014-0013-2 · Cited by 69
The antipsychotic potential of muscarinic allosteric modulation
Bridges, T. M., Lebois, E. P., Hopkins, C. R., Wood, M. R., Jones, C. K., Conn, P. J., & Lindsley, C. W. (2010) · Drug News & Perspectives · doi:10.1358/dnp.2010.23.4.1416977 · Cited by 68
D2 receptor regulation of synaptic burst firing in prefrontal cortical pyramidal neurons
Wang, Y., & Goldman‐Rakic, P. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400954101 · Cited by 67
Emerging drugs for schizophrenia
Agid, O., Kapur, S., & Remington, G. J. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.3.479 · Cited by 68
Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice
Brody, S. A., Geyer, M. A., & Large, C. H. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1421-2 · Cited by 68
Neurophysiological and neurochemical animal models of schizophrenia: Focus on glutamate☆
Bickel, S., & Javitt, D. C. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.05.005 · Cited by 68
Dynamic Regulation of Glutamatergic Postsynaptic Activity in Rat Prefrontal Cortex by Repeated Administration of Antipsychotic Drugs
Fumagalli, F., Frasca, A., Racagni, G., & Riva, M. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043786 · Cited by 66
NMDA receptor subunit expression in GABAergic interneurons in the prefrontal cortex: Application of laser microdissection technique
Xi, D., Keeler, B. E., Zhang, W., Houlé, J. D., & Gao, W. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.09.013 · Cited by 69
DNA Damage in Major Psychiatric Diseases
Raza, M. U., Tufan, T., Wang, Y., Hill, C. P., & Zhu, M. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9621-9 · Cited by 70
Homer 1a Gene Expression Modulation by Antipsychotic Drugs Involvement of the Glutamate Metabotropic System and Effects of D-Cycloserine
Polese, D. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00371-8 · Cited by 66
The role of estrogen and testosterone in female rats in behavioral models of relevance to schizophrenia
Gogos, A., Kwek, P., & van den Buuse, M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2389-y · Cited by 65
Differential effects of NMDA receptor antagonists at lower and higher doses on basal gamma band oscillation power in rat cortical electroencephalograms
Hiyoshi, T., Kambe, D., Karasawa, J.-I., & Chaki, S. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.037 · Cited by 67
Lead neurotoxicity: exploring the potential impact of lead substitution in zinc-finger proteins on mental health
Ordemann, J. M., & Austin, R. N. (2015) · Metallomics · doi:10.1039/c5mt00300h · Cited by 67
Crosstalk between endoplasmic reticulum stress and oxidative stress in schizophrenia: The dawn of new therapeutic approaches
Patel, S., Sharma, D., Kalia, K., & Tiwari, V. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.025 · Cited by 65
Modulation of Inhibitory Activity Markers by Intermittent Theta-burst Stimulation in Rat Cortex is NMDA-receptor Dependent
Labedi, A., Benali, A., Mix, A., Neubacher, U., & Funke, K. (2014) · Brain stimulation · doi:10.1016/j.brs.2014.02.010 · Cited by 67
Awake Rat Pharmacological Magnetic Resonance Imaging as a Translational Pharmacodynamic Biomarker: Metabotropic Glutamate 2/3 Agonist Modulation of Ketamine-Induced Blood Oxygenation Level Dependence Signals
Chin, C., Upadhyay, J., Marek, G. J., Baker, S. J., Zhang, M., Mezler, M., Fox, G. B., & Day, M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173880 · Cited by 63
Enhancement of endocannabinoid signalling during adolescence: Modulation of impulsivity and long-term consequences on metabolic brain parameters in early maternally deprived rats
Marco, E. M., Adriani, W., Canese, R., Podo, F., Viveros, M., & Laviola, G. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.10.006 · Cited by 62
Positive Allosteric Modulation of AMPA Receptors from Efficacy to Toxicity: The Interspecies Exposure-Response Continuum of the Novel Potentiator PF-4778574
Shaffer, C. L., Hurst, R. S., Scialis, R. J., Osgood, S. M., Bryce, D. K., Hoffmann, W. E., Lazzaro, J. T., Hanks, A. N., Lotarski, S. M., Weber, M. L., et al. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.204735 · Cited by 61
Validation of a combined image derived input function and venous sampling approach for the quantification of [18F]GE-179 PET binding in the brain
Galovic, M., Erlandsson, K., Fryer, T. D., Hong, Y. T., Manavaki, R., Sari, H., Chetcuti, S., Thomas, B. A., Fisher, M., Sephton, S. M., et al. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118194 · Cited by 61
Rats tested after a washout period from sub-chronic PCP administration exhibited impaired performance in the 5-Choice Continuous Performance Test (5C-CPT) when the attentional load was increased
Barnes, S. A., Young, J. W., & Neill, J. C. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.024 · Cited by 61
Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis
Zuo, D., Wu, Y., Yao, W.-X., Cao, Y., Wu, C., & Tanaka, M. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.05.010 · Cited by 61
Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function.
Moy, S., Perez, A., Koller, B., & Duncan, G. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.073 · Cited by 65
Mice Lacking the Immediate Early Gene Egr3 Respond to the Anti-Aggressive Effects of Clozapine Yet are Relatively Resistant to its Sedating Effects
Gallitano, A. L., Wozniak, D. F., Pehek, E. A., & Milbrandt, J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301505 · Cited by 61
Effects of the NMDA Antagonist Ketamine on Task-Switching Performance: Evidence for Specific Impairments of Executive Control
Stoet, G., & Snyder, L. H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300930 · Cited by 61
A comprehensive analysis of auditory event-related potentials and network oscillations in an NMDA receptor antagonist mouse model using a novel wireless recording technology
Schuelert, N., Dorner‐Ciossek, C., Brendel, M., & Rosenbrock, H. (2018) · Physiological Reports · doi:10.14814/phy2.13782 · Cited by 58
Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant
Kokane, S. S., Armant, R. J., Bolaños‐Guzmán, C. A., & Perrotti, L. I. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112548 · Cited by 63
Do NMDA-R antagonists re-create patterns of spontaneous gamma-band activity in schizophrenia? A systematic review and perspective
Bianciardi, B., & Uhlhaas, P. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.005 · Cited by 59
Comparison of automated home-cage monitoring systems: Emphasis on feeding behaviour, activity and spatial learning following pharmacological interventions
Robinson, L., & Riedel, G. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.06.013 · Cited by 60
The protective effects of omega−3 fatty acids against MK-801-induced neurotoxicity in prefrontal cortex of rat
Özyurt, B., Sarsılmaz, M., Akpolat, N., Özyurt, H., Akyol, Ö., Herken, H., & Kuş, İ. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.08.002 · Cited by 60
Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies
Woods, S. W., Walsh, B. C., Hawkins, K. A., Miller, T. J., Saksa, J. R., D’Souza, D. C., Pearlson, G. D., Javitt, D. C., McGlashan, T. H., & Krystal, J. H. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.09.008 · Cited by 61
Anhedonia, avolition, and anticipatory deficits: Assessments in animals with relevance to the negative symptoms of schizophrenia
Barnes, S. A., Der‐Avakian, A., & Markou, A. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.10.001 · Cited by 65
Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?
Stone, J. M. (2011) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125311400779 · Cited by 60
In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study
Chiu, P. W., Lui, S. S. Y., Hung, K. S. Y., Chan, R. C. K., Chan, Q., Sham, P. C., Cheung, E. F. C., & Mak, H. K. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.07.021 · Cited by 60
Psychiatric Comorbidities in Temporal Lobe Epilepsy: Possible Relationships between Psychotic Disorders and Involvement of Limbic Circuits
Kandratavicius, L., Lopes‐Aguiar, C., Bueno-Júnior, L. S., Romcy-Pereira, R. N., Hallak, J. E. C., & Leite, J. P. (2012) · Brazilian Journal of Psychiatry · doi:10.1016/j.rbp.2012.04.007 · Cited by 58
Transport mechanism and pharmacology of the human GlyT1
Wei, Y., Li, R., Meng, Y., Hu, T., Zhao, J. L., Gao, Y., Bai, Q., Li, N., & Zhao, Y. (2024) · Cell · doi:10.1016/j.cell.2024.02.026 · Cited by 60
The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders
Schwarz, E., & Bahn, S. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707658 · Cited by 59
The Neurobehavioral Pharmacology of Ketamine: Implications for Drug Abuse, Addiction, and Psychiatric Disorders
Trujillo, K. A., Smith, M. L., Sullivan, B., Heller, C. Y., Garcia, C., & Bates, M. L. S. (2011) · ILAR Journal · doi:10.1093/ilar.52.3.366 · Cited by 60
Mouse BOLD fMRI at ultrahigh field detects somatosensory networks including thalamic nuclei
Jung, W. B., Shim, H., & Kim, S. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.03.063 · Cited by 62
Hippocampal temporal-parietal junction interaction in the production of psychotic symptoms: a framework for understanding the schizophrenic syndrome
Wible, C. G. (2012) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2012.00180 · Cited by 56
The incidence of unpleasant dreams after sub-anaesthetic ketamine
Blagrove, M., Morgan, C. J. A., Curran, H. V., Bromley, L., & Brandner, B. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1377-3 · Cited by 59
Progress toward Positive Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5 (mGlu5)
Stauffer, S. R. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn2000519 · Cited by 59
Glutamate changes in healthy young adulthood
Marsman, A., Mandl, R. C. W., van den Heuvel, M. P., Boer, V. O., Wijnen, J. P., Klomp, D. W. J., Luijten, P. R., & Pol, H. E. H. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.11.003 · Cited by 64
Differential alterations of kainate receptor subunits in inhibitory interneurons in the anterior cingulate cortex in schizophrenia and bipolar disorder
Woo, T.-U. W., SHRESTHA, K., AMSTRONG, C., Minns, M., WALSH, J., & Benes, F. M. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.06.023 · Cited by 58
Cognitive dysfunction and glutamate reuptake: Effect of EAAT2 polymorphism in schizophrenia
Spangaro, M., Bosia, M., Zanoletti, A., Bechi, M., Cocchi, F., Pirovano, A., Lorenzi, C., Bramanti, P., Benedetti, F., Smeraldi, E., et al. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.06.030 · Cited by 57
Neuroimaging of frontal–limbic dysfunction in schizophrenia and epilepsy-related psychosis: Toward a convergent neurobiology
Butler, T., Weisholtz, D. S., Isenberg, N., Harding, E., Epstein, J., Stern, E. R., & Silbersweig, D. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.11.004 · Cited by 58
Impaired Midline Theta Power and Connectivity During Proactive Cognitive Control in Schizophrenia
Ryman, S. G., Cavanagh, J. F., Wertz, C. J., Shaff, N. A., Dodd, A. B., Stevens, B., Ling, J. M., Yeo, R. A., Hanlon, F. M., Bustillo, J., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.04.021 · Cited by 61
NMDA Antagonist Ketamine Reduces Task Selectivity in Macaque Dorsolateral Prefrontal Neurons and Impairs Performance of Randomly Interleaved Prosaccades and Antisaccades
Skoblenick, K. J., & Everling, S. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1510-12.2012 · Cited by 51
Chemical Modulation of Mutant mGlu 1 Receptors Derived from Deleterious GRM1 Mutations Found in Schizophrenics
Cho, H. P., García-Barrantes, P. M., Brogan, J. T., Hopkins, C. R., Niswender, C. M., Rodriguez, A. L., Venable, D. F., Morrison, R. D., Bubser, M., Daniels, J. S., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb500560h · Cited by 58
Anti-N-methyl-D-aspartate receptor encephalitis with serum anti-thyroid antibodies and IgM antibodies against Epstein-Barr virus viral capsid antigen: a case report and one year follow-up
Xu, C., Liu, L., Zhao, W., Li, J., Wang, R., Wang, S., Wang, D., Liu, M., Qiao, S.-S., & Wang, J. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-149 · Cited by 56

Authors: Olney, J. W., Newcomer, J. W., & Farber, N. B.
Affiliations: Washington University in St. Louis (US)
Corresponding author: Olney, John W
ORCID: Newcomer, John W
Farber, Nuri B
Venue: Journal of Psychiatric Research
Publisher: Elsevier BV
Published: 1999-11
Volume: 33
Issue: 6
Pages: 523-533
ISSN: 0022-3956 (ISSN-L)
DOI: 10.1016/s0022-3956(99)00029-1
OpenAlex: W2084120702
Cited by: 1,020
References: 63
Citations by year: 2026: 15 · 2025: 17 · 2024: 25 · 2023: 23 · 2022: 24 · 2021: 30 · 2020: 32 · 2019: 33 · 2018: 28 · 2017: 46 · 2016: 29 · 2015: 50 · 2014: 56 · 2013: 38 · 2012: 55
FWCI: 11.92
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Psychiatric Research (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5k02mh001510-05, 5k20da000290-05)
National Institute of Mental Health (MH33894, MH-01510)
National Institute on Drug Abuse (DA00290)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords: schizophrenia, NMDA receptor hypofunction, phencyclidine, NMDA receptor antagonists, neurotoxicity, psychotomimetic effects, schizophrenia treatment
MeSH terms: Animals, Disease Models, Animal, Enzyme Inhibitors, Humans, Models, Biological, Models, Psychological, Phencyclidine, Schizophrenia, Receptors, N-Methyl-D-Aspartate, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

NMDA receptor hypofunction model of schizophrenia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks